Namur Thrombosis and Hemostasis Center

Activities

Activities per year 2011 2013 2014 2016 2017 2018 2019 2022 2023 2023

• 48 Participation in conference
• 46 Invited talk
• 31 Publication peer-review
• 29 Oral presentation
• 40 More
  • 18 Participation in workshop, seminar, course
  • 4 Consultancy
  • 4 External Thesis
  • 4 Membership of committee
  • 3 Research/Teaching in a external institution
  • 2 Membership of council
  • 1 Participation to a Symposium, a study Day
  • 1 Editorial activity
  • 1 Jury
  • 1 Membership of board
  • 1 Membership of network

Activities per year

Search results

• Portola Pharmaceuticals

  Douxfils, J. (Expert)

  7 Jul 2019

  Activity: Consultancy types › Consultancy

• EDOXABAN – LIXIANA®Un inhibiteur direct du FXa approuvé dans la prévention des AVC et emboles systémiques dans la fibrillation auriculaire non-valvulaire

  Douxfils, J. (Consultant)

  26 Feb 2018

  Activity: Consultancy types › Consultancy

• POC Measurement of DOACs

  Douxfils, J. (Consultant)

  4 Jul 2017

  Activity: Consultancy types › Consultancy

• Assessment of thrombin generation in plasma samples of patients under anticoagulant treatment with ST Genesia system using STG - DrugScreen

  Douxfils, J. (Consultant)

  28 Apr 2017

  Activity: Consultancy types › Consultancy